Back
Viridian Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
VRDN
Viridian Therapeutics, Inc.
Last Price:
$28.79
Seasonality Move:
-15.82%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and VRDN is experiencing slight buying pressure.
Viridian Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.45 | Sell |
| 20-day SMA: | 32.03 | Sell |
| 50-day SMA: | 31.84 | Sell |
| 200-day SMA: | 22.06 | Buy |
| 8-day EMA: | 27.03 | Buy |
| 20-day EMA: | 18.09 | Buy |
| 50-day EMA: | 9.26 | Buy |
| 200-day EMA: | 2.64 | Buy |
Viridian Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.32 | Buy |
| Relative Strength Index (14 RSI): | 40.22 | Sell |
| Chaikin Money Flow: | 645263 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.43 - 33.39) | Sell |
| Bollinger Bands (100): | (23.32 - 32.78) | Buy |
Viridian Therapeutics, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viridian Therapeutics, Inc. Stock
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 30.07 while VRDN 8-day simple moving average is 30.45, which is a Sell signal.
-
The stock price of VRDN is 30.07 while Viridian Therapeutics, Inc. 20-day SMA is 32.03, which makes it a Sell.
-
Viridian Therapeutics, Inc. 50-day simple moving average is 31.84 while VRDN share price is 30.07, making it a Sell technically.
-
VRDN stock price is 30.07 and Viridian Therapeutics, Inc. 200-day simple moving average is 22.06, creating a Buy signal.
VRDN Technical Analysis vs Fundamental Analysis
Sell
47
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Is Viridian Therapeutics, Inc. a Buy or a Sell?
-
Viridian Therapeutics, Inc. stock is rated a SellThe current Viridian Therapeutics, Inc. [VRDN] share price is $30.07. The Score for VRDN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Viridian Therapeutics, Inc. Stock Info
Market Cap:
2.9B
Price in USD:
30.07
Share Volume:
1.8M
Viridian Therapeutics, Inc. 52-Week Range
52-Week High:
34.29
52-Week Low:
9.90
Sell
47
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Viridian Therapeutics, Inc. Share Price Forecast
-
What is the Viridian Therapeutics, Inc. stock price today?The Viridian Therapeutics, Inc. stock price is 30.07 USD today.
-
Will VRDN stock go up or go down?Viridian Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Viridian Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viridian Therapeutics, Inc. is overvalued.
Is Viridian Therapeutics, Inc. Stock a Buy?
-
Viridian Therapeutics, Inc. share price is 30.07 while VRDN 8-day exponential moving average is 27.03, which is a Buy signal.
-
The stock price of VRDN is 30.07 while Viridian Therapeutics, Inc. 20-day EMA is 18.09, which makes it a Buy.
-
Viridian Therapeutics, Inc. 50-day exponential moving average is 9.26 while VRDN share price is 30.07, making it a Buy technically.
-
VRDN stock price is 30.07 and Viridian Therapeutics, Inc. 200-day simple moving average is 2.64, creating a Buy signal.
Fundamental Analysis of Viridian Therapeutics, Inc.
Is Viridian Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $1.90 per share.
Technical Analysis of Viridian Therapeutics, Inc.
Should I short Viridian Therapeutics, Inc. stock?
-
VRDN Moving Average Covergence Divergence (MACD) indicator is 8.32, suggesting Viridian Therapeutics, Inc. is a Buy
-
Viridian Therapeutics, Inc. Relative Strength Index (RSI) is 40.22, which suggest Viridian Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Viridian Therapeutics, Inc. is (30.43 - 33.39), which suggest Viridian Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Viridian Therapeutics, Inc. is (23.32 - 32.78), which suggest Viridian Therapeutics, Inc. is a Buy
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.